Genomic changes in early stage of fatty liver

MU Kaida,ZHU Yunxia,WANG Shihong,WANG Chen,JIA WEiping

2013-01-01

Abstract:Objective To detect the whole genome expression in patients with mild fatty liver and to explore the changes of related genes in the early stage of nonalcoholic fatty liver disease (NAFLD). Methods Hepatic tissues were obtained from patients with benign focal hepatic lesions treated by liver surgery. Affymatrix GeneChip Human Genome U133 Plus 2.0 Array was used to investigate the gene expression in 4 samples with early-stage hepatic steatosis (15%―25% of hepatocytes with fat, fatty liver group) and 4 samples without fatty liver (<5% of hepatocytes with fat, control group). Real-time polymerase chain reaction (PCR) was used for the confirmation of differential genes. Results A total of 128 differential genes were identified from the samples. Among them, 63% were up-regulated and 37% were down-regulated in the fatty liver group; 37% were up-regulated and 63% were down-regulated in the control group. There were 102 genes participating in molecular function and 103 genes being cell components, 97 genes related to biologic process, and 53 genes involved in metabolic process. Pathway analysis showed that genes involved in triglyceride synthesis (1-acylglycerol-3-phosphate O-acyltransferase 2, glycerol kinase) and fatty acid transport (CD36) were upregulated, while genes involved in de novo fatty acid synthesis (chinken acetyl-coenzyme a carboxylase alpha , fatty acid synthase , elongation of very long chain fatty acids protein 6, ) were down-regulated in subjects with fatty liver. The gene expression of AGPAT2 and glycerol kinase and protein level of CD36 in fatty liver group were 1.6 times, 2.1 times and 1.4 times higher than the control group (P=0.006, 0.037 and 0.038, respectively). The gene expression of ACACA, FASN and ELOVL6 in fatty liver group was 60% (P=0.003), 40% (P=0.011) and 40% (P=0.032) of the control group respectively. There were no significant differences in the expression of carnitine palmityl transferase involved in β-oxidation and microsome triacylglycerol transferase participating in very low density lipoprotein secretion between two groups (both P>0.05). No changes were found in transcription factor, sterol regulatory element binding protein 1, nuclear factor or peroxisome proliferator-activated receptor α/λ in fatty liver group. But the new-found transcription factor, fibroblast growth factor 21 was upregulated in fatty liver group, which was 2.0 times higher than the control group (P=0.04). Conclusion Genes involved in fatty acid transport and triglyceride synthesis are upregulated, while genes involved in de novo fatty acid synthesis are down-regulated in early stage fatty liver, which indicates that increased fatty acid transport and triglyceride synthesis may be the earlier step in the development of NAFLD.